7-French Factor: Absence Of Fidelis Lead Gives St. Jude’s Riata A Boost
This article was originally published in The Gray Sheet
Executive Summary
Medtronic's recall of its Sprint Fidelis ICD leads will have only a small impact on overall implantable defibrillator demand, but the market leader's share will suffer as doctors seek the thinnest leads available, electrophysiologists suggested on an Oct. 29 conference call